Actinium Pharmaceuticals
ATNM
#10399
Rank
ยฃ33.52 M
Marketcap
ยฃ1.07
Share price
-3.38%
Change (1 day)
1.48%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): ยฃ7.34 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are ยฃ35.09 Million. In 2025 the company made an earning of -ยฃ27.03 Million, an increase over its 2024 earnings that were of -ยฃ31.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ7.34 M-127.19%
2025 -ยฃ27.03 Million-13.95%
2024 -ยฃ31.41 Million-18.87%
2023 -ยฃ38.72 Million52.24%
2022 -ยฃ25.43 Million36.61%
2021 -ยฃ18.62 Million11.48%
2020 -ยฃ16.7 Million1.46%
2019 -ยฃ16.46 Million-7.37%
2018 -ยฃ17.77 Million-11.46%
2017 -ยฃ20.07 Million10.67%
2016 -ยฃ18.14 Million15.7%
2015 -ยฃ15.68 Million-14.86%
2014 -ยฃ18.41 Million129.19%
2013 -ยฃ8.04 Million-8.55%
2012 -ยฃ8.79 Million
2010 ยฃ0 M-152.15%
2009 -ยฃ0.02 Million-39.8%
2008 -ยฃ0.02 Million120.29%
2007 -ยฃ0.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-ยฃ27.74 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.14 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.11 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA